Living With Nonmelanoma Skin Cancer Symposium at Dana-Farber Cancer Institute
Date: January 22, 2024
We are thrilled to welcome you to our Nonmelanoma Skin Cancer Patient-Focused Symposium in collaboration with the skin cancer experts at Dana-Farber Cancer Institute. This insightful virtual event features topics for those living with advanced skin cancer. Hear from leading cancer specialists and special guests as they share their expertise and experiences.
About Dana-Farber Cancer Institute
Founded in 1947, Dana-Farber Cancer Institute is committed to providing adults and children with cancer the best treatments available today, while leading the research to advance the understanding, diagnosis, treatment, cure and prevention of cancer and related diseases. Located in Boston, Massachusetts, Dana-Farber is a Comprehensive Cancer Center as designated by the National Cancer Institute and an affiliate of the Harvard Medical School.
This symposium is an opportunity for patients and caregivers to learn about nonmelanoma skin cancers from the medical experts from Dana-Farber Cancer Institute. This event is FREE and open to all and will be presented virtually.
New Treatments for Squamous Cell Carcinoma
Justine V. Cohen, DO
Oncologist
Dana-Farber Cancer Institute
What is Mohs Surgery & What is the Role in Advanced Skin Cancer?
Abigail H. Waldman, MD, FAAD
Clinical Director MOHS Surgery
Brigham and Women’s Hospital
What is Merkel Cell Carcinoma (MCC)
Ann W. Silk, MD, MS
Co-Director of the Merkel Cell Carcinoma
Center of Excellence
Dana-Farber Cancer Institute
Radiation Therapy for Merkel Cell Carcinoma (MCC)
Danielle N. Margalit, MD, MPH
Dana-Farber Cancer Institute
Systemic Treatment for Merkel Cell Carcinoma (MCC)
Karam Khaddour, MD, MS
Oncologist
Dana-Farber Cancer Institute